Literature DB >> 33475249

Novel genetic testing model: A collaboration between genetic counselors and nephrology.

Louise Amlie-Wolf1, Laura Baker1, Olivia Hiddemen1, Morgan Thomas1, Christine Burke2, Caroline Gluck2, Joshua J Zaritsky2, Karen W Gripp1.   

Abstract

Many barriers to genetic testing currently exist which delay or prevent diagnosis. These barriers include wait times, staffing, education, and cost. Specialists are able to identify patients with disease that may need genetic testing, but lack the genetics support to facilitate that testing in the most cost, time, and medically effective manner. The Nephrology Division and the Genetic Testing Stewardship Program at Nemours A.I. duPont Hospital for Children created a novel service delivery model in which nephrologists and genetic counselors collaborate in order to highlight their complementary strengths (clinical expertise of nephrologists and genetics and counseling skills of genetic counselors). This collaboration has reduced many barriers to care for our patients. This workflow facilitated the offering of genetic testing to 76 patients, with 86 tests completed over a 20-month period. Thirty-two tests were deferred. Twenty-seven patients received a diagnosis, which lead to a change in their medical management, three of whom were diagnosed by cascade family testing. Forty-two patients had a negative result and 16 patients had one or more variants of uncertain significance on testing. The inclusion of genetic counselors in the workflow is integral toward choosing the most cost and time effective genetic testing strategy, as well as providing psychosocial support to families. The genetic counselors obtain informed consent, and review genetic test results and recommendations with the patient and their family. The availability of this program to our patients increased access to genetic testing and helps to provide diagnoses and supportive care.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  genetic testing; nephrology; utilization management

Mesh:

Year:  2021        PMID: 33475249     DOI: 10.1002/ajmg.a.62088

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  3 in total

1.  Molecular Genetic Testing for Kidney Disorders During the COVID-19 Pandemic.

Authors:  Susan M Kirwin; Katherine M Robbins; Kathleen M B Vinette; Lee Hirata; Karen W Gripp; Vicky L Funanage
Journal:  Dela J Public Health       Date:  2021-12-15

2.  Impact of Genetic Testing on Human Health:: The Current Landscape and Future for Personalized Medicine.

Authors:  Vicky L Funanage
Journal:  Dela J Public Health       Date:  2021-12-15

3.  Analysis of Molecular Genetic Testing Referrals for Inherited Retinal Dystrophies in a Quebec Tertiary Care Center Over a Decade.

Authors:  Alexandre Lachance; Mélanie Hébert; Marc Hébert; Christian Salesse; Serge Bourgault; Ali Dirani
Journal:  Clin Ophthalmol       Date:  2022-02-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.